Franchise Cannabis is a global, fully integrated cannabis company developing world class medical cannabis operations and with a focus on entering strategic markets as they open up. We have a strong growth profile over the coming quarters with continued market share growth in Europe, underpinned by our dominant distribution platform in Germany, as well as increasing cannabis extract inventories in Latin America.
Download Our Investor Materials
September 16, 2019Franchise Cannabis’s German Subsidiary Commits to Purchase of Medical Cannabis from MJardin’s Halifax Facility
July 21, 2019Franchise Cannabis Reports a Surge in Patient Growth at German Subsidiary and Increased Supply from the Netherlands
June 7, 2019Franchise Cannabis Announces Reverse Takeover Transaction and Concurrent Subscription Receipt Financing